NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
16/02/2019
Voltar para busca
Dado oficial do USPTO
Q
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000077271620Classe
35, 41, 42, 44, 45
Pedido
77271620
Registro
3568317
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
16/02/2019
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 41, 42, 44, 45
Data de depósito
05/09/2007
Data de registro
27/01/2009
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/02/2019
Última transação
16/02/2019
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/02/1982
Primeiro uso no comércio
01/02/1982
Código do desenho
5
Tipo de titular
03
Localização do titular
PARSIPPANY, NJ, US
Examinador
BEN, LINDSEY HEATHER
Unidade examinadora
L80
Localização atual
TMEG LAW OFFICE 108
Titulares e representantes
Titulares
IQVIA INC.
Quintiles Transnational Corp.
Representantes
ARLENE D. HANKS Moore & Van Allen PLLC
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Computerized database management and data processing services in the fields of pharmaceuticalpharmacogenomicbiotechnical and medical products and devices; manufacturers' and independent sales representatives in the fields of pharmaceuticalspharmacogenomicbiotechnicalmedical products and devices; marketing services for otherscreating and managing product sales and product launch programs in the fields of pharmaceuticalspharmacogenomicbiotechnicalmedical products and devices; business marketing consulting services in the fields of pharmaceuticalspharmacogenomicbiotechnicalmedical products and devices; market research and analysis services in the fields of pharmaceuticalspharmacogenomicbiotechnicalmedical products and devices; personnel recruitment and placement; providing business informationinformation useful for achieving and maintaining regulatory approval and market introduction of drugsdevices and biologics
Classe 41
Educational and training servicesconducting training programsseminarsclassesconferences and workshops in the fields of health carehealth management and disease managementpharmaceutical sales skillspharmaceutical and health productsdistributing course materials in connection therewith
Classe 42
Clinical research and testing services in the fields of pharmaceuticalspharmacogenomicbiotechnicalmedical products and devices; product development consultation in the fields of medical products and devices; healthcare policy research and development services; laboratory testing services in the fields of pharmaceuticalpharmacogenomicbiotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managingmonitoring and coordinating clinical studies on human subjects for others
Classe 44
Providing healthmedicalpharmaceuticalhealth management and disease management information to others; medical evaluation servicesdeveloping and implementing disease management and treatment protocols and patient outcome analysis services; consulting services in the fields of health caremedical and pharmaceuticals
Classe 45
Regulatory research in the pharmaceutical industrybiotechnology industry and the medical and diagnostics industry; consultation services in the field of compliance evaluation to insure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others in the fields of pharmaceuticalpharmacogenomicbiotechnical and medical products and devices; consulting services in the fields of regulatory affairsmanufacturing compliance and validation; providing regulatory information and implementation services relating to the development and validation of drugsdevices and biologics
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
16/02/2019
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
16/02/2019
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
16/02/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16/02/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
17/01/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/12/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
17/10/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/08/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
27/01/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
19/10/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/10/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
27/05/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
20/05/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/01/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/01/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/01/2015
E815
TEAS SECTION 8 & 15 RECEIVED
17/12/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/11/2014
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
22/04/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
27/01/2009
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
19/12/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
17/12/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
26/11/2008
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
26/11/2008
IUAF
USE AMENDMENT FILED
20/11/2008
EISU
TEAS STATEMENT OF USE RECEIVED
20/11/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
10/06/2008
PUBO
PUBLISHED FOR OPPOSITION
18/03/2008
NPUB
NOTICE OF PUBLICATION
27/02/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
13/02/2008
ALIE
ASSIGNED TO LIE
13/02/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/01/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/12/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/12/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/12/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/10/2007
GNRT
NON-FINAL ACTION E-MAILED
23/10/2007
CNRT
NON-FINAL ACTION WRITTEN
23/10/2007
DOCK
ASSIGNED TO EXAMINER
17/10/2007
MPMK
NOTICE OF PSEUDO MARK MAILED
11/09/2007
NWAP
NEW APPLICATION ENTERED
10/09/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace Q ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.